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In vitro studies demonstrated that suboptimal levels of BH 4 can lead to uncoupling of NO synthase, which could become a major source of superoxide anion and thereby cause oxidative stress in vascular disease (41) . Previous in vivo studies suggest that oxidation of BH 4 , as a consequence of increased oxidative stress in cardiovascular disease, may contribute to endothelial dysfunction in diabetic rats and DOCA-salt hypertensive mice (19, 33) . Furthermore, alterations in BH 4 levels have been reported in animal models of hypercholesterolemia and atherosclerosis (1, 7, 25, 40) . However, expression and activity of GTPCH I, a rate-limiting enzyme in biosynthesis of BH 4 , during atherogenesis have not been determined.
MATERIALS AND METHODS
Experimental animals. Four-to five-week-old male wild-type (C57BL/6J) and homozygous apolipoprotein E (apoE)-deficient mice (C57BL/6J-ApoE Tm1Unc ) were obtained from Jackson Laboratory (Bar Harbor, ME). Housing facilities and all experimental protocols were approved by the Institutional Animal Care and Use Committee of the Mayo Clinic and comply with the "Guiding Principles in the Care and Use of Animals" of the American Physiological Society. Wild-type and apoE-deficient mice were fed a lipid-rich, Westerntype diet (0.15% cholesterol and 42% of milk fat by weight; TD88137, Harlan Teklad, Madison, WI) for up to 14 mo to accelerate the development of atherosclerosis (26, 48) . At 3, 5, 9, or 14 mo after treatments, the mice were anesthetized (60 mg/kg body wt ip pentobarbital), and blood samples were collected through right ventricle puncture. Blood was immediately transferred to a tube containing heparin and centrifuged at 4°C for 10 min. Plasma was stored at Ϫ80°C until assayed. Plasma lipid profile was determined using a colorimetric-based assay on a Cobas Mira system. Aortas were carefully removed and dissected free from connective tissue in cold (4°C) modified Krebs-Ringer bicarbonate solution (in mmol/l: 118.6 NaCl, 4.7 KCl, 2.5 CaCl 2, 1.2 MgSO4, 1.2 KH2PO4, 25.1 NaHCO3, 10.1 glucose, and 0.026 EDTA).
Lesion assessment. Aortas were opened longitudinally and fixed in 4% buffered paraformaldehyde for 2 h. Intraluminal lipid-rich lesions were stained in supersaturated Sudan IV solution in 38% isopropanol for an additional 16 h (32). After being stained, the aortas were washed in distilled water and kept in 4% formalin. Serial images of the submerged vessels were captured with a digital camera. Lesion analysis was performed with Image Pro Plus 3.0 software. The area of lesion formation in each aorta was measured and expressed as %lesion area per total area of the aorta.
Measurements of tissue BH 4 and 7,8-BH2 ϩ biopterin levels. Freshly isolated whole aortas and brains were homogenized in extraction buffer containing 50 mmol/l Tris (pH 7.4), 1 mmol/l dithiothreitol, and 1 mmol/l EDTA at 4°C and were centrifuged at 10,000 g (8 min at 4°C). One whole aorta is needed for n ϭ 1 experiment.
Biopterin levels were determined after differential oxidation in acid (which converts both BH4 and 7,8-BH2 to biopterin) and base (which converts only 7,8-BH2 to biopterin) conditions by reverse-phase HPLC (Beckman Coulter, Fullerton, CA) with a fluorescence detector (Jasco) as described previously (7) . Data were collected and analyzed by 32 Karat chromatography software (Beckman Coulter) and normalized against tissue protein levels. BH4 content was calculated from the difference in biopterin levels after acid and base oxidations.
To evaluate the contribution of endothelium to BH4 synthesis, aortas with and without endothelium were studied in parallel. The dissected aorta was opened lengthwise and fixed on a siliconated dish. Endothelial surface was incubated with 0.1% collagenase in PBS for 5 min at room temperature (38) . Endothelial cells were removed carefully and softly using a surgical blade; the aorta was washed twice with extraction buffer and was homogenized as described above. The removal of endothelium was confirmed by the absence of endothelial NO synthase protein expression.
Measurement of GTPCH I activity. Tissue supernatant homogenates, prepared as in the biopterin assay, were filtered using a Sephadex G25M column (Amersham, Piscataway, NJ) to remove endogenous neopterin, BH4, and phenylalanine. GTPCH I enzymatic activity was assayed using reverse-phase HPLC method (Beckman Coulter) by measurements of neopterin, which was derived from dihydroneopterin triphosphate after oxidation and phosphate treatment (39) . Results were normalized against tissue protein levels.
Western blot analysis. Fresh aortas and brains were homogenized on ice in lysis buffer (pH 7.5) containing 50 mmol/l Tris ⅐ HCl, 0.1 mmol/l EDTA, 0.1 mmol/l EGTA, 0.1% SDS, 0.1% deoxycholate, 1% Igepal, and mammalian protease inhibitor cocktail (Sigma) and then centrifuged. Equal amounts of protein (100 g/lane) from all groups were separated by SDS-PAGE and transferred to nitrocellulose membrane (Amersham) using a semidry electrophoretic transfer cell for Western analysis. Polyclonal anti-GTPCH-I was raised in rabbits against a peptide ERELPRPGASPPAEK of the mouse GTPCH-I (National Center for Biotechnology Information accession number NP032128; Invitrogen, Carlsbad, CA). The specificity of the GTPCH I antibody was verified by incubation of vascular smooth muscle cells in the presence or absence of LPS (1 g/ml) for 6 h. GTPCH I is selectively increased in LPS-stimulated cells only (unpublished observations). Bands were visualized by enhanced chemiluminescence with the use of a commercially available kit (Amersham) and normalized on actin (Sigma, St. Louis, MO).
Calculations and statistical analysis. Results are expressed as means Ϯ SE, and n indicates the number of animals from which tissues were harvested. Control and apoE-deficient mice groups were compared by two-way ANOVA for multiple comparisons. For simple comparisons between two age-matched groups of control and apoEdeficient mice, an unpaired Student's t-test was used where appropriate. A value of P Ͻ 0.05 was considered significant.
RESULTS
Mice characteristics. Plasma cholesterol and LDL and HDL levels were slightly increased in wild-type mice after 3, 5, 9, and 14 mo of Western-type diet (P Ͻ 0.05; Table 1 ). In contrast, Western diet treatment elevated plasma cholesterol levels in apoE-deficient mice (P Ͻ 0.05; Table 1 ). Of note, cholesterol and LDL levels were significantly elevated in apoE-deficient mice as compared with wild-type mice throughout the study (P Ͻ 0.05; Table 1 ). Interestingly, after 3 mo of treatment, plasma HDL levels were higher in apoE-deficient mice as compared with wild-type mice (P Ͻ 0.05; Table 1 ). After 5 mo of treatment onward, HDL levels declined.
Morphology. Before the beginning of Western-type diet treatment, there were no visible atherosclerotic plaques found in the aorta of 4-to 5-wk-old apoE-deficient mice. Only a few aortic lesion spots were observed after 3 mo of treatment (6.4 Ϯ 0.3% of total area; P Ͻ 0.05 vs. 0 mo; n ϭ 5). Five months of treatment markedly increased aortic plaque formation to 27.4 Ϯ 2.9% in apoE-deficient mice (P Ͻ 0.05 vs. 0-and 3-mo treatment; n ϭ 5). This increase was further enhanced after 9 and 14 mo on a Western diet (36.5 Ϯ 0.4 and 44.3 Ϯ 3.7% of total area, respectively; P Ͻ 0.05; n ϭ 4). In wild-type mice, there was no lesion formation observed during the time course of the study.
Tissue BH 4 levels. Time-dependent studies showed that BH 4 levels were significantly increased in apoE-deficient mice aortas as compared with wild-type mice after 5 mo on Western diet (P Ͻ 0.05; Fig. 1B ). This increase was further enhanced after 9 and 14 mo of treatment (P Ͻ 0.05). Oxidative products of BH 4 , 7,8-BH 2 and biopterin, were slightly increased in both wild-type and apoE-deficient mice after 5 and 9 mo as compared with before treatment (P Ͻ 0.05). However, they were not different between wild-type and apoE-deficient mice aortas over the course of the study (Fig. 1C) .
To evaluate the site of BH 4 synthesis, we determined BH 4 levels in endothelial cells. We found that ϳ85% of total BH 4 is present in endothelial cells of control wild-type mice, whereas only 15% is localized in the media (Fig. 2) . Interestingly, BH 4 levels were doubled in the endothelium of agematched apoE-deficient mice on Western diet for 9 mo. However, removal of the endothelium did not eliminate all BH 4 ; levels of BH 4 were increased more than eight times in media of apoE-deficient mice (Fig. 2) .
In contrast to the aorta, BH 4 levels were unchanged in the brain of wild-type and apoE-deficient mice (Fig. 3A) , suggest- ing that the increase in aortic BH 4 levels is tissue specific and related to development of atherosclerosis (6, 20) . In addition, there was no evidence of increased oxidation of BH 4 in the brain of wild-type and apoE-deficient mice (Fig. 3B) . . Bar graphs show tetrahydrobiopterin (BH4) levels (B) and 7,8-dihydrobiopterin ϩ biopterin levels (C) in aortas of wild-type (WT; C57BL/6J) and apolipoprotein E (apoE)-deficient mice on Westerntype diet. Time-dependent studies showed that BH4 levels were increased in apoEdeficient mice aortas as compared with WT mice after 5 mo on diet (B). This increase was further enhanced after 9 and 14 mo. In contrast to BH4, the levels of its oxidative products 7,8-dihydrobiopterin and biopterin were not different between wild-type and apoE-deficient mice aortas over the course of this study (C). Results are means Ϯ SE (n ϭ 5-8). *P Ͻ 0.05 vs. age-matched C57BL/6J mice; †P Ͻ 0.05 vs. untreated mice (0 mo); #P Ͻ 0.05 vs. treated mice for 3 mo (two-way ANOVA). Fig. 2 . Effect of endothelium removal (EϪ) on tetrahydrobiopterin (BH4) levels in aortas of WT ( C57BL/6J) and apoE-deficient mice on a Western-type diet for 9 mo is shown. Note that removal of the endothelium almost eliminated BH4 in aortas of WT mice but not in apoE-deficient mice. Results are means Ϯ SE (n ϭ 5). *P Ͻ 0.05 vs. aortas of same species with endothelium (Eϩ); †P Ͻ 0.05 vs. C57BL/6J mice without endothelium (two-way ANOVA). 
GTPCH I enzymatic activity and protein expression.
To evaluate the mechanisms of increased BH 4 levels in apoEdeficient mice, we determined GTPCH I enzymatic activity. GTPCH I activity was significantly increased in apoE-deficient mice aortas as compared with wild-type mice after 5 mo on a Western-type diet (Fig. 4) . This increase was further enhanced after 9 and 14 mo (Fig. 4) , indicating that the increase in BH 4 levels is due to the increased de novo biosynthesis of BH 4 via GTPCH I enzyme.
Western blot analysis revealed increased GTPCH I protein expression in aortas of apoE-deficient mice as compared with wild-type mice after 3 mo (P Ͻ 0.05; Fig. 5, A and B) , which was further enhanced after 5 and 9 mo of treatment with a Western diet (P Ͻ 0.05; Fig. 5, A and B) . In contrast, GTPCH I protein expressions were not different in the brain of wildtype and apoE-deficient mice during the time course of the study (Fig. 5C) .
DISCUSSION
This is the first study to investigate vascular biopterin metabolism during progression of atherosclerosis in apoEdeficient mice. We report several novel findings. First, BH 4 levels are selectively increased in the aorta of atherosclerotic apoE-deficient mice as compared with age-matched wild-type mice. Second, endothelium is a major source of BH 4 in wild-type mice, whereas both endothelium and vascular media contribute to BH 4 synthesis in apoE-deficient mice. Third, elevation of BH 4 levels in atherosclerotic aorta is caused by the increased protein expression and enzymatic activity of GTPCH I, the rate-limiting enzyme required for de novo biosynthesis of BH 4 .
It is well established that lesions accommodate active sites of inflammation and immune responses, whereas cytokines appear to orchestrate the chronic development of atherosclerosis, leading to the formation of complex atherosclerotic plaques (47) . In addition, we and others have shown that production of superoxide anion is increased in endothelial and vascular smooth muscle cells and atheromatous plaques, suggesting that oxidative stress is present in atherosclerotic arteries (6, 22) . Furthermore, NO-mediated, endothelium-dependent relaxations to acetylcholine and Ca 2ϩ ionophore are impaired in atherosclerotic aortas of apoE-deficient mice (1, 6, 20, 43, 46) . Superoxide anion scavengers improve endothelial function, indicating that inactivation of NO by superoxide anion is responsible for endothelial dysfunction in atherosclerotic apoE-deficient mice (6, 20) .
It has been proposed that BH 4 is an important molecular target for oxidation by reactive oxygen species and that reduced bioavailability of vascular BH 4 may result in impairment of NO-mediated endothelium-dependent vasodilatation. Indeed, there are several reports showing that in vivo administration of BH 4 improves endothelium-dependent vasodilatation in hypercholesterolemia (34) , cigarette smoking (10), diabetes (33) , and atherosclerosis (36) . Significant reduction of BH 4 levels, caused by both increased oxidation and/or decreased biosynthesis of BH 4 , has been reported in blood vessels obtained from experimental animals with diabetes and hypertension (19, 33) . However, in the present study, we provide evidence that BH 4 levels are not different in aortas of wild-type Fig. 4 . GTP-cyclohydrolase I (GTPCH I) activity was increased in apoEdeficient mice aortas as compared with WT (C57BL/6J) mice after 5 mo on a Western-type diet. This increase was further enhanced after 9 and 14 mo on diet. Results are means Ϯ SE (n ϭ 5-9). *P Ͻ 0.05 vs. age-matched C57BL/6J mice; †P Ͻ 0.05 vs. untreated mice (0 mo) (two-way ANOVA). and apoE-deficient mice after 3 mo of treatment with Western diet, despite increased cholesterol and LDL levels, suggesting that BH 4 and BH 2 are not affected during early stages of hypercholesterolemia. In contrast, after 5 mo of treatment onward, BH 4 levels were significantly increased in atherosclerotic aorta of apoE-deficient mice, which is in line with the previous reports (1, 7) . Interestingly, levels of 7,8-BH 2 and biopterin, oxidative products of BH 4 , remained unchanged in the aorta of wild-type and apoE-deficient mice during the time course of the study, suggesting that oxidation of BH 4 does not contribute to reported endothelial dysfunction induced by hypercholesterolemia (6, 20, 46) . However, the findings are at variance with reported reduction of BH 4 levels in apoE-deficient mice overexpressing endothelial NO synthase (25) or in hypercholesterolemic rabbits (40) . The reason for discrepancy is not clear, but the most likely explanation is that studies by Ozaki et al. (25) and Vasquez-Vivar et al. (40) used atherosclerotic animals that had ϳ30 times higher circulating levels of cholesterol as compared with control animals. In contrast, we and others have observed that, in apoE-deficient mice, total cholesterol levels were increased only about three times (1, 13) . Thus it appears that hypercholesterolemia tends to increase BH 4 levels, whereas only severe increase in cholesterol levels can reduce availability of BH 4 . In contrast, in the brain, BH 4 levels and GTPCH I protein expression were not different between wild-type and apoE-deficient mice, supporting our conclusion regarding selective increase in BH 4 biosynthesis in the arterial wall.
To evaluate the mechanisms of increased BH 4 levels in apoE-deficient mice, we determined vascular GTPCH I enzymatic activity. We provide evidence that GTPCH I activity is augmented in apoE-deficient mice aortas after 5 mo on a Western diet, indicating that the selective increase in BH 4 levels was due to the increased de novo biosynthesis of BH 4 . These findings are consistent with reported high plasma levels of neopterin in patients with atherosclerosis and coronary syndromes (2, 31, 35, 44) . Interestingly, we also detected upregulation of GTPCH I protein expression in the aorta of apoE-deficient mice after 5 and 9 mo, further suggesting that increased BH 4 levels found in atherosclerotic aortas are caused by both increased enzymatic activity and protein expression of GTPCH I. The exact mechanism responsible for upregulation of GTPCH I and BH 4 synthesis is unclear. However, atherosclerosis is an inflammatory disease, and the presence of inflammatory cytokines in atherosclerotic blood vessels has been well documented (29, 47) . In addition, recent studies (4, 12, 16, 21, 42) confirmed the involvement of the cytokines and chemokines in the progression of atherosclerosis in apoEdeficient mice. Consistent with the findings of the present study, inflammatory cytokines such as tumor necrosis factor-␣, interferon-␥, and interleukin-1␤ stimulate BH 4 biosynthesis via upregulation of GTPCH I activity and protein expression in cultured vascular endothelial cells (11, 14, 28, 30, 45) .
BH 4 exerts its vascular protective effect by stimulation of NO production and/or protection of proteins from nitration by peroxynitrite or nitrogen dioxide (3, 18) . Both pharmacologic and genetic elevation of BH 4 in aortas of apoE-deficient mice has an antiatherogenic effect (1, 7) . In addition, a recent study (15) showed that BH 4 deficiency in the mutant hph-1 mouse accelerates atherosclerosis progression. On the basis of these observations, we speculate that elevation of BH 4 biosynthesis during atherosclerosis development is an adaptive response designed to optimize NO production. Indeed, in our previous study, we demonstrated that in aortas obtained from apoEdeficient mice fed a Western diet for 6 mo, total enzymatic activity of NOS is three times higher as compared with control arteries (7). This phenomenon was caused by increased expression and activity of inducible NO synthase, which is localized for the most part in the vascular media of apoE-deficient mice (17) . Thus coordinated upregulation of inducible NO synthase and GTPCH I in atherosclerotic vessels is most likely caused by inflammatory cytokines (5, 28) . However, a detected increase of BH 4 is apparently insufficient to prevent the uncoupling of endothelial NO synthase (1) . Excessive demand of BH 4 in atherosclerotic arteries expressing very high levels of inducible NO synthase could create relative deficiency of cofactor. This would explain the beneficial effects of BH 4 supplementation on endothelial function of experimental animals and humans with atherosclerosis (1, 36) .
In conclusion, our results demonstrate that BH 4 (but not 7,8-BH 2 ) levels are selectively increased in atherosclerotic apoE-deficient mouse aortas. Elevation of BH 4 levels is most likely caused by the increased de novo biosynthesis via GTPCH I pathway. The exact role of arterial GTPCH I upregulation in pathogenesis of atherosclerosis is unclear and remains to be determined.
